Human papillomavirus (HPV) infection
Institut national de santé publique du Québec I
ACKOWLEDGEMENTS
This project was made possible through the support of the “Table nationale de concertation en
maladies infectieuses”, which ensured that it remained a priority for the Ministère de la Santé et des
Services sociaux, the Institut national de santé publique du Québec and the Directions régionales de
santé publique. We would also like to thank the Institut national de santé publique du Québec for
agreeing to oversee this project.
Finally, we would like to thank the many experts who agreed to be part of the consultation process.
Michel Alary, M.D., Ph. D.
Professor
Institut national de santé publique du Québec
Population Health Research Unit, Laval University
Hôpital du Saint-Sacrement
Department of Social and Preventive Medicine, Faculty of Medicine
Université Laval, Quebec
Isabelle Bairati, M.D, Ph. D.
Associate professor
Faculty of Medicine
Université Laval, Quebec
Medical consultant
Direction de la santé publique de Québec
François Coutlée, M.D., F.R.C.P.
Microbiologist - Infectologist
Professor
Department of Microbiology and Immunology
Université de Montréal, Montréal
Centre hospitalier universitaire de Montréal
Michèle Deschamps, Ph. D.
Researcher, Cancer Team
Direction de santé publique Montréal-Centre
Régie régionale de la santé et des services sociaux de Montréal-Centre
Alex Ferenczy, M.D.
Professor of Pathology and of Gynecology and Obstetrics
McGill University
Pathology Department
Sir Mortimer B. Davis Jewish General Hospital, Montreal